Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 5.69% is 44% above its 3-year average of 3.95%, near the high end of its 3-year range (0.00%–6.36%).
As of the fiscal period ended Wednesday, December 31, 2025. 5.56% below its 12-month average of 6.03%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
5.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
6.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
3.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.56%
CURRENT VS 3Y AVG
+44.05%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-33.29%
vs the sector median at left
Medline Inc.
Market Cap
$32.77B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
N/A
Market Cap
$31.59B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$31.31B
Return on Invested Capital (ROIC)
-13.41%
TTM Avg
-4.17%
3Y Avg
-0.53%
5Y Avg
0.76%
Market Cap
$34.72B
Return on Invested Capital (ROIC)
8.23%
TTM Avg
8.41%
3Y Avg
8.23%
5Y Avg
6.99%
Market Cap
$29.85B
Return on Invested Capital (ROIC)
6.62%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$36.28B
Return on Invested Capital (ROIC)
13.74%
TTM Avg
4.84%
3Y Avg
-6.97%
5Y Avg
-13.43%
Market Cap
$28.33B
Return on Invested Capital (ROIC)
19.56%
TTM Avg
18.66%
3Y Avg
17.73%
5Y Avg
16.77%
Market Cap
$27.61B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$27.56B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $32.77B | 5.69% | 6.03% | 3.95% | N/A |
| Zoetis Inc. (ZTS)vs › | $31.59B | 21.54% | 21.87% | 20.30% | 19.27% |
| Centene Corp. (CNC)vs › | $31.31B | -13.41% | -4.17% | -0.53% | 0.76% |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 8.23% | 8.41% | 8.23% | 6.99% |
| Biogen Inc. (BIIB)vs › | $29.85B | 6.62% | 7.71% | 8.64% | 10.90% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 13.74% | 4.84% | -6.97% | -13.43% |
| ResMed Inc. (RMD)vs › | $28.33B | 19.56% | 18.66% | 17.73% | 16.77% |
| DexCom, Inc. (DXCM)vs › | $27.61B | 16.61% | 13.40% | 11.07% | 9.62% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 8.84% | 8.56% | 8.37% | 9.38% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 35.46% | 38.26% | 37.51% | 36.01% |
ROIC
5.7%
ROE
8.6%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 5.69% |
| 2024-12-31 | 6.36% |
| 2023-12-31 | 3.75% |
| 2022-12-31 | 0.00% |
